NOT-CA-21-078: Notice of Pre-Application Webinar for RFA-CA-21-031, Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes (ENICTO; U01 Clinical Trial Required) and RFA-CA-21-032, (ENICTO Coordinating Center; U24 Clinical Trial Not Allowed)

Notice of Pre-Application Webinar for RFA-CA-21-031, Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes (ENICTO; U01 Clinical Trial Required) and RFA-CA-21-032, (ENICTO Coordinating Center; U24 Clinical Trial Not Allowed)

Notice Number:

NOT-CA-21-078

Key Dates

Release Date:

May 6, 2021

Related Announcements

RFA-CA-21-031 - Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes (ENICTO) in Cancer Survivors Consortium (U01 Clinical Trial Required)

RFA-CA-21-032 - Coordinating Center for Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes (ENICTO) in Cancer Survivors Consortium (U24 Clinical Trial Not Allowed)

Issued by

National Cancer Institute (NCI)

Purpose

The National Cancer Institute (NCI) will hold a pre-application webinar on Wednesday, May 26, 2021, from 12:00 - 1:00 PM (EST) for Funding Opportunity Announcements (FOAs) RFA-CA-21-031, Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes (ENICTO) in Cancer Survivors Consortium (U01 Clinical Trial Required) and RFA-CA-21-032, Coordinating Center for Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes (ENICTO) in Cancer Survivors Consortium (U24 Clinical Trial Not Allowed).

Involved NCI staff members will provide a brief overview of the above-referenced FOAs for potential applicants by explaining the goals and objectives for the FOAs and answering questions from webinar attendees.

Please submit questions in avance by May 24, 2021 to [email protected] with "ENICTO in Cancer Survivors Consortium Webinar Questions" in the subject line. Time-permitting, attendees may also be able to submit questions during the webinar.

To join the Webinar, pre-registration is required through Webex: Register for the Webinar

Specific webinar information will be provided upon registration.

Although highly encouraged, participation in this webinar is optional and not required for the submission of applications in response to RFA-CA-21-031 or RFA-CA-21-032. A webinar recording, as well as frequently asked questions (FAQs) and corresponding answers will be posted on the BRP Archived Events webpage about two weeks following the webinar.

Inquiries

Please direct all inquiries to:

Frank M. Perna, Ed.D., Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-6782
Email: [email protected]